Literature DB >> 6821854

Carcinoids: the association of histologic growth pattern and survival.

L A Johnson, P Lavin, C G Moertel, L Weiland, Y Dayal, W G Doos, S A Geller, H S Cooper, F Nime, S Massé, I W Simson, H Sumner, E Fölsch, P Engstrom.   

Abstract

There are five generally accepted carcinoid histologic growth patterns, i.e., insular, trabecular, glandular, undifferentiated, and mixed. To determine their possible prognostic significance, a panel of pathologists studied the growth patterns of 138 carcinoids collected from an Eastern Cooperative Oncology Group carcinoid advanced stage disease chemotherapy investigation. Survival times were measured from date of initial pathologic diagnosis of carcinoid disease to date of either death or last follow-up. Significant differences were observed in survival times between the five major growth patterns (P less than 0.001). Within the mixed growth pattern group, significant differences in survival time were also observed (P approximately 0.05). In decreasing order of median survival time in years, the growth patterns ranked as follows: mixed insular plus glandular, 4.4; insular, 2.9; trabecular, 2.5; mixed insular plus trabecular, 2.3; three pooled low incidence rate mixed growth patterns, 1.4; glandular, 0.9; and undifferentiated, 0.5. Histologic growth patterns are recommended as a stratification factor in future studies of this disease.

Entities:  

Mesh:

Year:  1983        PMID: 6821854     DOI: 10.1002/1097-0142(19830301)51:5<882::aid-cncr2820510522>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

Review 1.  The diversity and commonalities of gastroenteropancreatic neuroendocrine tumors.

Authors:  Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin
Journal:  Langenbecks Arch Surg       Date:  2011-01-28       Impact factor: 3.445

2.  Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors:  M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

3.  Gastric carcinoids: a statistical evaluation of 1,094 cases collected from the literature.

Authors:  J Soga
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

4.  DNA distribution pattern in intestinal carcinoid tumors.

Authors:  G Cohn; K Erhardt; B Cedermark; B Hamberger; G Auer
Journal:  World J Surg       Date:  1986-08       Impact factor: 3.352

5.  Nuclear DNA patterns and survival in metastasizing ileal carcinoids.

Authors:  A P Nobin; K Erhardt; G Auer; S Falkmer; H Mårtensson
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

6.  Proceedings of the 2017 National Toxicology Program Satellite Symposium.

Authors:  Susan A Elmore; Famke Aeffner; Dinesh S Bangari; Torrie A Crabbs; Stacey Fossey; Shayne C Gad; Wanda M Haschek; Jessica S Hoane; Kyathanahalli Janardhan; Ramesh C Kovi; Gail Pearse; Lyn M Wancket; Erin M Quist
Journal:  Toxicol Pathol       Date:  2017-11-07       Impact factor: 1.902

7.  Current Treatment Options in Gastroenteropancreatic Neuroendocrine Carcinoma.

Authors:  Katharine E H Thomas; Brianne A Voros; J Philip Boudreaux; Ramcharan Thiagarajan; Eugene A Woltering; Robert A Ramirez
Journal:  Oncologist       Date:  2019-01-11

8.  Anorectal carcinoid tumors. Is aggressive surgery warranted?

Authors:  P Sauven; J A Ridge; S H Quan; E R Sigurdson
Journal:  Ann Surg       Date:  1990-01       Impact factor: 12.969

9.  Feasibility and efficacy of combined cisplatin plus irinotecan chemotherapy for gastroenteropancreatic neuroendocrine carcinomas.

Authors:  Z H Lu; J Li; M Lu; X T Zhang; J Li; J Zhou; X C Wang; J F Gong; J Gao; Y Li; L Shen
Journal:  Med Oncol       Date:  2013-07-18       Impact factor: 3.064

10.  Primary hepatic carcinoid tumours.

Authors:  M Nikfarjam; V Muralidharan; C Christophi
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.